Number of Shares
2.87 Mil
Current Holdings Value*
$51.97 Mil
% of Portfolio
12.16%
Total Estimate Gain
$32.29 Mil
% of Total Estimate Gain
102.76%

Medicxi Ventures Management (Jersey) Ltd's NewAmsterdam Pharma Co NV Holding Summary

As of 2025-06-30, Medicxi Ventures Management (Jersey) Ltd held 2.87 Mil shares of NewAmsterdam Pharma Co NV(NAMS), totaling $51.97 Mil. This investment constitutes 12.16% of their stock portfolio, and Medicxi Ventures Management (Jersey) Ltd now holds 2.56% of the outstanding NewAmsterdam Pharma Co NV(NAMS) stock.

The initial trade took place in 2022Q4. And since then Medicxi Ventures Management (Jersey) Ltd has made 2 purchases of NAMS, at an average price of $10.95, for a total of 2.87 Mil shares. Based on historical transaction data and NAMS's current price of $22.20, Medicxi Ventures Management (Jersey) Ltd's estimated gain on his NAMS holdings is $32.29 Mil, reflecting a 102.76% gain to date.

Medicxi Ventures Management (Jersey) Ltd NAMS ($22.20) Holding Chart

Medicxi Ventures Management (Jersey) Ltd NAMS ($22.20) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1